Edition:
India

Madrigal Pharmaceuticals Inc (MDGL.OQ)

MDGL.OQ on NASDAQ Stock Exchange Capital Market

40.19USD
17 Nov 2017
Change (% chg)

$-0.27 (-0.67%)
Prev Close
$40.46
Open
$40.27
Day's High
$40.54
Day's Low
$39.43
Volume
13,070
Avg. Vol
19,995
52-wk High
$52.30
52-wk Low
$13.11

Latest Key Developments (Source: Significant Developments)

Madrigal Pharmaceuticals reports Q3 loss per share of $0.68
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Madrigal Pharmaceuticals Inc :Madrigal Pharmaceuticals reports 2017 third quarter financial results.Qtrly loss per share $0.68 ‍​.‍As of Sept 30, had cash, cash equivalents and marketable securities of $62.1 million, versus $40.5 million at December 31, 2016​.On track to report top-line results for nash late this year and hefh early in 2018​.  Full Article

Rebecca Taub, M.D reports 10.38 pct stake in Madrigal Pharmaceuticals
Tuesday, 2 Aug 2016 

Madrigal Pharmaceuticals Inc : Rebecca Taub, M.D reports 10.38 pct stake in Madrigal Pharmaceuticals as of July 22, 2016 - SEC Filing Source - http://bit.ly/2auxhO2 Further company coverage: [MDGL.O] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Paul A. Friedman, M.D. reports 8.25 pct stake in Madrigal Pharmaceuticals
Tuesday, 2 Aug 2016 

Madrigal Pharmaceuticals Inc : Paul A. Friedman, M.D. reports 8.25 pct stake in Madrigal Pharmaceuticals as of July 22, 2016 - SEC Filing Source - http://bit.ly/2amL8Hp Further company coverage: [MDGL.O] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Bay City Capital LLC reports 49.9 pct stake in Madrigal Pharmaceuticals - SEC Filing
Saturday, 30 Jul 2016 

Madrigal Pharmaceuticals Inc :Bay City Capital LLC reports 49.9 pct stake in Madrigal Pharmaceuticals Inc as of July 22, 2016 - SEC Filing.  Full Article